Similar articles for PMID: 19068958

Year	Number of Results
1971	1
1982	1
1992	2
1994	1
1996	1
1997	3
1998	1
2000	1
2004	1
2005	7
2006	6
2007	4
2008	5
2009	6
2010	7
2011	5
2012	2
2013	2
2014	3
2015	6
2016	1
2017	7
2018	1
2019	1
2020	1
2024	0

1

Van Hattem S, Bootsma AH, Thio HB. Van Hattem S, et al. Cleve Clin J Med. 2008 Nov;75(11):772, 774, 776-7 passim. doi: 10.3949/ccjm.75.11.772. Cleve Clin J Med. 2008. PMID: 19068958 Free article. Review.

2

Injection-site skin lesions following pen-injection treatment in a 59-year-old woman with insulin-treated Type 2 diabetes mellitus.

Winkler G, Sápi Z, Pál B, Molnár L. Winkler G, et al. Diabet Med. 1997 Dec;14(12):1078-9. doi: 10.1002/(SICI)1096-9136(199712)14:12<1078::AID-DIA481>3.0.CO;2-G. Diabet Med. 1997. PMID: 9455937 No abstract available.

3

Cutaneous manifestations of diabetes mellitus.

Perez MI, Kohn SR. Perez MI, et al. J Am Acad Dermatol. 1994 Apr;30(4):519-31; quiz 532-4. doi: 10.1016/s0190-9622(94)70058-3. J Am Acad Dermatol. 1994. PMID: 8157778 Review.

4

[Skin changes in diabetes mellitus].

Meurer M, Stumvoll M, Szeimies RM. Meurer M, et al. Hautarzt. 2004 May;55(5):428-35. doi: 10.1007/s00105-004-0726-3. Hautarzt. 2004. PMID: 15083279 Review. German.

5

Cutaneous Manifestations of Diabetes Mellitus: A Review.

Lima AL, Illing T, Schliemann S, Elsner P. Lima AL, et al. Am J Clin Dermatol. 2017 Aug;18(4):541-553. doi: 10.1007/s40257-017-0275-z. Am J Clin Dermatol. 2017. PMID: 28374407 Review.

6

[Cardiovascular effects and safety of glucose-lowering drugs: current situation].

Masmiquel L. Masmiquel L. Semergen. 2014 Mar;40(2):80-8. doi: 10.1016/j.semerg.2012.12.001. Epub 2013 Feb 4. Semergen. 2014. PMID: 24655910 Review. Spanish.

7

Type 2 diabetes mellitus and risk of malignancy: is there a strategy to identify a subphenotype of patients with increased susceptibility to endogenous and exogenous hyperinsulinism?

Müssig K, Staiger H, Kantartzis K, Fritsche A, Kanz L, Häring HU. Müssig K, et al. Diabet Med. 2011 Mar;28(3):276-86. doi: 10.1111/j.1464-5491.2010.03132.x. Diabet Med. 2011. PMID: 21309835 Review.

8

[Cutaneous complications of insulin therapy. A drug-induced condition on the decline].

Piérard-Franchimont C, Hermanns-Lê T, Scheen AJ, Piérard GE. Piérard-Franchimont C, et al. Rev Med Liege. 2005 May-Jun;60(5-6):564-5. Rev Med Liege. 2005. PMID: 16035329 Free article. Review. French.

9

Insulin glargine (Lantus) and cancer risk.

[No authors listed] [No authors listed] Med Lett Drugs Ther. 2009 Aug 24;51(1319):67-8. Med Lett Drugs Ther. 2009. PMID: 19696708 No abstract available.

10

Where now for insulin glargine--a time for pragmatic medicine?

Thomson GA, Craig R. Thomson GA, et al. Int J Clin Pract. 2009 Oct;63(10):1413-5. doi: 10.1111/j.1742-1241.2009.02170.x. Epub 2009 Aug 18. Int J Clin Pract. 2009. PMID: 19689485 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

71 results

Results by year